• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Molecular Partners to Present at HC Wainwright and Morgan Stanley Healthcare Conferences

Share:

September 14, 2020

Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built proteins known as DARPin® therapeutics, today announced that Patrick Amstutz, chief executive officer, will be presenting at the HC Wainwright 22nd Annual Global Investments Conference taking place September 14-16, 2020, as well as participating in a fireside chat at the Morgan Stanley Global Healthcare Conference taking place September 14-18, 2020.

Details for the presentations are as follows:

HC Wainwright 22nd Annual Global Investments Conference
Presentation Date: Monday, September 14, 2020
Presentation Time: 11:30 a.m. ET

Morgan Stanley Global Healthcare Conference
Presentation Date: Wednesday, September 16, 2020
Presentation Time: 1:15 p.m. ET

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

A webcast of the presentations will be available on the Molecular Partners website.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Health Systems Will be Challenged to Compete in a Commoditized Telehealth MarketHealth Systems Will be Challenged to Compete in a Commoditized Telehealth Market
  • Germany Introduces Digital Supply Act to Digitalise HealthcareGermany Introduces Digital Supply Act to Digitalise Healthcare
  • Cigna, Celgene join $23M funding round for AI-powered precision healthcare startupCigna, Celgene join $23M funding round for AI-powered precision healthcare startup
  • Healthtech Developments in APAC – a 2019 ReviewHealthtech Developments in APAC – a 2019 Review
  • Commercializing Digital Therapeutic Solutions: Key Lessons Learned to WatchCommercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch
  • Medicus IT Acquires Managed Service Provider Nexus Practice It ServicesMedicus IT Acquires Managed Service Provider Nexus Practice It Services
  • Telehealth and Cybersecurity: What You Should KnowTelehealth and Cybersecurity: What You Should Know
  • TearLab Corporation Confirms Merger DiscussionsTearLab Corporation Confirms Merger Discussions

Trending This Week

  • Immuno-Oncology Pipeline Cuts Explained
  • Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
  • USFDA Accepts Glenmark’s Application to Initiate a Human Trial of Molecules for Advanced Solid Tumors and Lymphomas
  • Concentra’s Buy Offer May Jeopardize Jounce’s Merger with Redx
  • Pfizer Acquires Seagen For $43B To Tackle Cancer
  • Janssen’s Novel Dengue Antiviral Demonstrates ‘strong Protection’ in Pre-Clinical Data

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications